TODD NGUYEN: Open Payments
NPI 1063270015 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $141 |
| Lilly USA, LLC | 2 | $58 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Indivior Inc. | 1 | $35 |
| Novo Nordisk Inc | 1 | $32 |
| ViiV Healthcare Company | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: Korlym, SHINGRIX, SUBLOCADE, MOUNJARO, Wegovy, CABENUVA, ZEPBOUND, Yeztugo.
Industry payments across CA — which companies pay providers there.
